Cargando…
Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus
Influenza virus infections are a major cause of respiratory disease in humans. Neuraminidase inhibitors (NAIs) are the primary antiviral medication used to treat ongoing influenza infections. However, NAIs are not always effective for controlling virus shedding and lung inflammation. Other concerns...
Autores principales: | Madrid, Darling Melany de C., Gu, Weihong, Artiaga, Bianca L., Yang, Guan, Loeb, Julia, Hawkins, Ian K., Castleman, William L., Lednicky, John A., Richt, Jürgen A., Driver, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635317/ https://www.ncbi.nlm.nih.gov/pubmed/36337191 http://dx.doi.org/10.3389/fvets.2022.999507 |
Ejemplares similares
-
Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs
por: Artiaga, Bianca L., et al.
Publicado: (2022) -
α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant
por: Artiaga, Bianca L., et al.
Publicado: (2016) -
Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells
por: Driver, John P., et al.
Publicado: (2020) -
Rapid control of pandemic H1N1 influenza by targeting NKT-cells
por: Artiaga, Bianca L., et al.
Publicado: (2016) -
A single-cell analysis of thymopoiesis and thymic iNKT cell
development in pigs
por: Gu, Weihong, et al.
Publicado: (2022)